Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Nakamura H et al. – Risk of CVD is higher in patients with moderate CKD compared with those with normal renal function/mild CKD, and was significantly reduced by treatment with pravastatin. Pravastatin also exerted beneficial effects on renal function in patients with moderate CKD.
Related Articles
The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study
BMC Cardiovascular Disorders, 11/13/09
Relevance Score: 94%
Is normalising haemoglobin in patients with CKD harmful and if so, why
Journal of Renal Care, 11/17/09
Relevance Score: 93%
Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease
Nephrology Dialysis Transplantation, 11/12/09
Relevance Score: 93%
Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/09/09
Relevance Score: 93%
Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events
Clinical and Experimental Nephrology, 11/06/09
Relevance Score: 93%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Reversible Myocardial Hypertrophy Induced by Tacrolimus in a Pediatric Heart Transplant Recipient: Case Report
Transplantation Proceedings, 11/20/09
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
Aortic Arch Recoarctation after the Norwood Stage I Palliation: The Comparative Accuracy of Blood Pressure Cuff and Echocardiographic Doppler Gradients in Detecting Significant Obstruction
Congenital Heart Disease, 11/20/09
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension
Journal of Hypertension, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


